Skip to main content
SpringerLink
Log in

Myelodysplastic Stem Cells: Gene Expression Profiling

  • Chapter
  • First Online:
Book cover Stem Cells and Cancer Stem Cells, Volume 8

Part of the book series: Stem Cells and Cancer Stem Cells ((STEM,volume 8))

  • 1198 Accesses

Abstract

Myelodysplastic syndromes (MDS) represent a group of diseases associated with bone marrow failure arising from the interaction between a clonal and deranged hematopoietic stem cell (HSC) and a deregulated bone marrow microenvironment. Several abnormalities have been described in the development of myelodysplastic stem cells which give origin to dysplastic hematopoiesis, including increased apoptosis, decreased survival, depletion of early hematopoietic cells and abnormal differentiation. Gene expression profiling (GEP) studies have allowed a clear discrimination between normal and myelodysplastic HSCs. Moreover, distinct gene expression signatures have been associated with disease stage (early versus advanced), prognosis, morphology and presence of recurrent chromosomal abnormalities, such as monosomy 7/deletion 7q, trisomy 8 and deletion 5q. Most interestingly, GEP has allowed the identification of crucial genes and biologic pathways deranged in MDS including among all interferon signaling, ribosomal protein biogenesis, immune response, Wnt/ β-catenin signalling, cell cycle control and DNA damage response. These pathways beside shedding light on the comprehension of MDS pathobiology, may represent the basis for further investigations and realization of a more targeted approach in the therapeutic management of these diseases. Strictly correlated to GEP, miRNA profiling identified distinct miRNAs deregulated in MDS, which can significantly influence expression of coding transcripts in myelodysplastic stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bacher U, Kohlmann A, Haferlach T (2010) Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies. Cancer Treat Rev 36:637–646

    Article  CAS  PubMed  Google Scholar 

  • Baratti MO, Moreira YB, Traina F, Costa FF, Verjovski-Almeida S, Olalla-Saad ST (2010) Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts. BMC Med Genomics 3:30

    Article  PubMed Central  PubMed  Google Scholar 

  • Benito AI, Bryant E, Loken MR, Sale GE, Nash RA, John Gass M, Deeg HJ (2003) NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Leuk Res 27:425–436

    Article  CAS  PubMed  Google Scholar 

  • Boultwood J, Pellagatti A, Cattan H, Lawrie CH, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Fidler C, Cazzola M, Hellström-Lindberg E, Wainscoat JS (2007) Gene expression profiling of CD34+ cells in patients with the 5q- syndrome. Br J Haematol 139:578–589

    Article  CAS  PubMed  Google Scholar 

  • Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H, Littlewood TJ, Malcovati L, Della Porta MG, Jädersten M, Killick S, Giagounidis A, Bowen D, Hellström-Lindberg E, Cazzola M, Wainscoat JS (2008) The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 3:e1970

    Article  PubMed Central  PubMed  Google Scholar 

  • Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, Sloand EM, Young NS (2004) Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 104:4210–4218

    Article  CAS  PubMed  Google Scholar 

  • D’Alò F, Greco M, Criscuolo M, Voso MT (2010) New treatments for myelodysplastic syndromes. Mediterr J Hematol Infect Dis 2:e2010021

    PubMed Central  PubMed  Google Scholar 

  • Dostalova Merkerova M, Krejcik Z, Votavova H, Belickova M, Vasikova A, Cermak J (2011) Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. Eur J Hum Genet 19:313–319

    Article  PubMed  Google Scholar 

  • Giachelia M, D’Alò F, Fabiani E, Saulnier N, Di Ruscio A, Guidi F, Hohaus S, Voso MT, Leone G (2011) Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. Leuk Res 35:465–471

    Article  CAS  PubMed  Google Scholar 

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531–537

    Article  CAS  PubMed  Google Scholar 

  • Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088

    CAS  PubMed  Google Scholar 

  • Gueller S, Komor M, Nowak D, Baldus CD, de Vos S, Hoelzer D, Ottmann OG, Hofmann WK (2010) Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome. Exp Hematol 38:718–732

    Article  CAS  PubMed  Google Scholar 

  • Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP (2002) Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 100:3553–3560

    Article  CAS  PubMed  Google Scholar 

  • Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O’Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP (2009) Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 113:1315–1325

    Article  CAS  PubMed  Google Scholar 

  • Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503–3510

    Article  PubMed  Google Scholar 

  • Miyazato A, Ueno S, Ohmine K, Ueda M, Yoshida K, Yamashita Y, Kaneko T, Mori M, Kirito K, Toshima M, Nakamura Y, Saito K, Kano Y, Furusawa S, Ozawa K, Mano H (2001) Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 98:422–427

    Article  CAS  PubMed  Google Scholar 

  • Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE (2002) Involvement and functional impairment of the CD34(+)CD38(−)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 100:259–267

    CAS  PubMed  Google Scholar 

  • Nilsson L, Edén P, Olsson E, Månsson R, Astrand-Grundström I, Strömbeck B, Theilgaard-Mönch K, Anderson K, Hast R, Hellström-Lindberg E, Samuelsson J, Bergh G, Nerlov C, Johansson B, Sigvardsson M, Borg A, Jacobsen SE (2007) The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes. Blood 110:3005–3014

    Article  CAS  PubMed  Google Scholar 

  • Nimer SD (2008) MDS: a stem cell disorder–but what exactly is wrong with the primitive hematopoietic cells in this disease? Hematol Am Soc Hematol Educ Program 2008:43–51

    Article  Google Scholar 

  • Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S, Campbell LJ, Wang L, Langford CF, Fidler C, Oscier D, Aul C, Wainscoat JS, Boultwood J (2006) Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood 108:337–345

    Article  CAS  PubMed  Google Scholar 

  • Pellagatti A, Jädersten M, Forsblom AM, Cattan H, Christensson B, Emanuelsson EK, Merup M, Nilsson L, Samuelsson J, Sander B, Wainscoat JS, Boultwood J, Hellström-Lindberg E (2007) Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proc Natl Acad Sci USA 104:11406–11411

    Article  CAS  PubMed  Google Scholar 

  • Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jädersten M, Killick S, Verma A, Norbury CJ, Hellström-Lindberg E, Wainscoat JS, Boultwood J (2010) Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia 24:756–764

    Article  CAS  PubMed  Google Scholar 

  • Prall WC, Czibere A, Grall F, Spentzos D, Steidl U, Giagounidis AA, Kuendgen A, Out H, Rong A, Libermann TA, Germing U, Gattermann N, Haas R, Aivado M (2009) Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome. Int J Hematol 89:173–187

    Article  CAS  PubMed  Google Scholar 

  • Rhyasen GW, Starczynowski DT (2011) Deregulation of microRNAs in myelodysplastic syndrome. Leukemia 26(1):13–22. doi:10.1038/leu.2011.221

    PubMed  Google Scholar 

  • Sridhar K, Ross DT, Tibshirani R, Butte AJ, Greenberg PL (2009) Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression. Blood 114:4847–4858

    Article  CAS  PubMed  Google Scholar 

  • Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, Seidl T, Soneji S, Leach J, Bowen D, Chapman C, Standen G, Massey E, Robinson L, Vadher B, Kaczmarski R, Janmohammed R, Clipsham K, Carr A, Vyas P (2005) Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 106:2982–2991

    Article  CAS  PubMed  Google Scholar 

  • Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon

    Google Scholar 

  • Testa U (2011) Leukemia stem cells. Ann Hematol 90:245–271

    Article  CAS  PubMed  Google Scholar 

  • Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, Eaves C (2004) Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood 103:4285–4293

    Article  CAS  PubMed  Google Scholar 

  • Theilgaard-Mönch K, Boultwood J, Ferrari S, Giannopoulos K, Hernandez-Rivas JM, Kohlmann A, Morgan M, Porse B, Tagliafico E, Zwaan CM, Wainscoat J, Van den Heuvel-Eibrink MM, Mills K, Bullinger L (2011) Gene expression profiling in MDS and AML: potential and future avenues. Leukemia 25:909–920. doi:10.1038/leu.2011.48

    Article  PubMed  Google Scholar 

  • Ueda M, Ota J, Yamashita Y, Choi YL, Ohki R, Wada T, Koinuma K, Kano Y, Ozawa K, Mano H (2003) DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. Br J Haematol 123:288–296

    Article  CAS  PubMed  Google Scholar 

  • Vasikova A, Budinska E, Belickova M, Cermak J, Bruchova H (2009) Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome. Neoplasma 56:335–342

    Article  CAS  PubMed  Google Scholar 

  • Votavova H, Grmanova M, Dostalova Merkerova M, Belickova M, Vasikova A, Neuwirtova R, Cermak J (2011) Differential expression of microRNAs in CD34+ cells of 5q- syndrome. J Hematol Oncol 4:1

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Xie W, Wang X, Du W, Liu W, Qin X, Huang S (2010) Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes. Cytometry A 77:840–848

    Article  PubMed  Google Scholar 

  • Zeng W, Miyazato A, Chen G, Kajigaya S, Young NS, Maciejewski JP (2006) Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood 107:167–175

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Haematology, Univesità Cattolica del Sacro Cuore, “A. Gemelli”, Largo A. Gemelli 8, 00164, Rome, Italy

    Emiliano Fabiani

  2. Istituto di Ematologia, Universita’ Cattolica Sacro Cuore, Rome, Italy

    Francesco D’Alò, Giuseppe Leone & Maria Teresa Voso

Authors
  1. Emiliano Fabiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco D’Alò
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Teresa Voso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emiliano Fabiani .

Editor information

Editors and Affiliations

  1. Biology, Kean University, Union, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Fabiani, E., D’Alò, F., Leone, G., Voso, M.T. (2012). Myelodysplastic Stem Cells: Gene Expression Profiling. In: Hayat, M. (eds) Stem Cells and Cancer Stem Cells, Volume 8. Stem Cells and Cancer Stem Cells, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4798-2_6

Download citation

Publish with us

Policies and ethics

Search

Navigation